SuperworthTriSalus Life Sciences shares outstanding TLSI
Diluted shares outstanding, averaged over each quarter, from 2021.
- Latest quarter, to Jun 30, 2026
- 58.3M
- On a year earlier
- +77.2%
- more shares
TriSalus Life Sciences had 58.3M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 77.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 46.9M | +70% |
| FY2024 | 27.5M | +19% |
| FY2023 | 23.2M | +25% |
| FY2022 | 18.5M | −26% |
| FY2021 | 25M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 58.3M | +77% | |
| Q1 FY26 | 52.3M | +83% | |
| Q4 FY25 | 46.9M | +70% | |
| Q3 FY25 | 43.1M | +62% | |
| Q2 FY25 | 32.9M | +38% | |
| Q1 FY25 | 28.5M | +22% | |
| Q4 FY24 | 27.5M | +19% | |
| Q3 FY24 | 26.5M | +101% | |
| Q2 FY24 | 23.9M | +5256% | |
| Q1 FY24 | 23.3M | +44% | |
| Q4 FY23 | 23.2M | +25% | |
| Q3 FY23 | 13.2M | +4125% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on TriSalus Life Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.